InvestorsHub Logo
Followers 15
Posts 2455
Boards Moderated 0
Alias Born 02/04/2007

Re: drugmanrx post# 65262

Saturday, 06/24/2017 6:04:04 PM

Saturday, June 24, 2017 6:04:04 PM

Post# of 85898
Results of Operations for the Three and Nine Month Periods Ended February 28, 2017 and February 29, 2016

 

Revenues

 

Our operating results for the three and six month periods ended February 28, 2017 and February 29, 2016 are summarized as follows:

 

  Three Months Ended  Nine Months Ended   February 28, 2017 and February 29, 2016  

February 28, 2017 and

February 29, 2016

   2017  2016  2017  2016 Revenue $-  $30,299  $-  $81,067 Operating expenses $195,847  $144,827  $435,379  $769,700 Other income (expense) $1,122,545  $(180,188) $(658,330) $(672,015)Net income (loss) $926,698  $(294,716) $(1,093,709) $(1,360,648)

 

Our net income for the three months ended February 28, 2017 was $926,698 of which a loss of $4,866 was attributable to the minority interest. Our net loss for nine months ended February 28, 2017 was $ 1,093,709 of which $14,616 was attributable to the minority interest.

 

Revenue generated during the three months ended February 28, 2017 was nil compared to revenue of $30,299 during the same period in 2016. Revenue generated during the nine months ended February 28, 2017 was nil compared to revenue of $81,067 during the same period in 2016. The decrease in revenues is due to the expiry of our contract with Alstom, which was not renewed.